Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

Clinical trial NCT01572662 · COMPLETED

Trial details

NCT number: NCT01572662
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Acute Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myeloproliferative Diseases Non-Hodgkins Lymphoma Hodgkins Lymphoma Multiple Myeloma Myelodysplastic Syndrome

Start date: 2012-04-11
Primary completion: 2022-08-11
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.